In the weekly dosing cohort, patients treated with sutacimig achieved an estimated 87% reduction in ATBR. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

A groundbreaking gene therapy trial has successfully restored hearing in individuals with a rare form of congenital deafness.

Researchers in the United Kingdom say they have successfully trialed what could become the world's first gene therapy for Huntington's disease – a fatal neurodegenerative disorder that is typically ...

Add Yahoo as a preferred source to see more of our stories on Google. The latest FDA recognition is supported by positive results from several studies Novartis has announced that the US Food and Drug ...

The FDA granted breakthrough therapy designation to plixorafenib for adult patients with BRAF V600E–mutated high-grade glioma ...

Sanofi (NASDAQ:SNY) is one of the best undervalued stocks under $50 to invest in now. Sanofi (NASDAQ:SNY) announced on March ...

This week in oncology, regulatory updates and practice-changing trial data took center stage. From FDA timeline extensions to ...

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA ...

Hemab Therapeutics, a late stage clinical biotechnology company developing novel prophylactic therapeutics for serious, underserved coagulation disorders, today announced that the U.S. Food and Drug ...

CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing ...